128 related articles for article (PubMed ID: 35487830)
21. Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant.
Eroglu C; Pala C; Kaynar L; Yaray K; Aksozen MT; Bankir M; Zararsız G; Orhan O; Gündog M; Yıldız OG; Eser B; Cetin M; Unal A
Leuk Lymphoma; 2013 Nov; 54(11):2474-9. PubMed ID: 23442062
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Mori T; Aisa Y; Kato J; Yamane A; Nakazato T; Shigematsu N; Okamoto S
Am J Hematol; 2012 Apr; 87(4):349-53. PubMed ID: 22290459
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.
Sakellari I; Gavriilaki E; Chatziioannou K; Papathanasiou M; Mallouri D; Batsis I; Bousiou Z; Bouziana S; Constantinou V; Douka V; Apostolou C; Iskas M; Lalayanni C; Athanasiadou A; Sotiropoulos D; Yannaki E; Gianouzakos V; Anagnostopoulos A
Ann Hematol; 2018 Oct; 97(10):1987-1994. PubMed ID: 29869673
[TBL] [Abstract][Full Text] [Related]
24. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
25. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.
Savani BN; Montero A; Wu C; Nlonda N; Read E; Dunbar C; Childs R; Solomon S; Barrett AJ
Biol Blood Marrow Transplant; 2005 Mar; 11(3):223-30. PubMed ID: 15744241
[TBL] [Abstract][Full Text] [Related]
26. Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
Beyzadeoglu M; Arpaci F; Surenkok S; Ozyigit G; Oysul K; Caglar K; Ataergin S; Yenicesu M; Kaya A
Saudi Med J; 2008 Jun; 29(6):832-6. PubMed ID: 18521460
[TBL] [Abstract][Full Text] [Related]
27. Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.
Motohashi K; Fujisawa S; Onizuka M; Kako S; Sakaida E; Shono K; Tatara R; Doki N; Mori T; Sakura T; Aotsuka N; Fuji E; Tomita N; Kawai N; Saitoh T; Usuki K; Taguchi J; Watanabe R; Kobayashi S; Yano S; Kanamori H; Takahashi S; Okamoto S
Bone Marrow Transplant; 2015 Nov; 50(11):1476-9. PubMed ID: 26191948
[No Abstract] [Full Text] [Related]
28. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
[TBL] [Abstract][Full Text] [Related]
29. Pubertal outcomes of children transplanted with allogeneic stem cells after myeloablative total body irradiation or busulfan: Influence of age and sex is confirmed, while a role of chronic graft-versus-host disease in delayed puberty onset is revealed.
Weinhard S; Wiedemann A; Leheup B; Dalle JH; Lebon Labich B; Pochon C
Pediatr Transplant; 2020 Sep; 24(6):e13773. PubMed ID: 32701220
[TBL] [Abstract][Full Text] [Related]
30. Conditioning regimens for acute lymphoblastic leukaemia allografts.
Marks DI
Bone Marrow Transplant; 2007 Mar; 39(6):377; author reply 378. PubMed ID: 17277787
[No Abstract] [Full Text] [Related]
31. Multiple osteochondromas following irradiation-containing conditioning in severe combined immunodeficiency.
Grunebaum E; Daneman A; Murguia-Favela L; Manson D; Kim VH; Roifman CM; Grunebaum M
Br J Haematol; 2013 May; 161(3):446-8. PubMed ID: 23384194
[No Abstract] [Full Text] [Related]
32. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
33. Secondary amenorrhoea after total body irradiation in pre-puberty.
Albanese A; Leiper AD; Pritchard J; Stanhope R
J R Soc Med; 1996 Feb; 89(2):113P-4P. PubMed ID: 8683497
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation.
van Bekkum DW
Rheumatology (Oxford); 1999 Aug; 38(8):757-61. PubMed ID: 10501428
[TBL] [Abstract][Full Text] [Related]
35. Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.
Kelsey CR; Horwitz ME; Chino JP; Craciunescu O; Steffey B; Folz RJ; Chao NJ; Rizzieri DA; Marks LB
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):812-8. PubMed ID: 20932682
[TBL] [Abstract][Full Text] [Related]
36. Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.
Blum W; Brown R; Lin HS; Zehnbauer B; Khoury H; Goodnough LT; Westervelt P; Vij R; DiPersio J; Adkins D
Biol Blood Marrow Transplant; 2002; 8(11):608-18. PubMed ID: 12463480
[TBL] [Abstract][Full Text] [Related]
37. Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiation.
Hunter HM; Peggs K; Powles R; Rahemtulla A; Mahendra P; Cavenagh J; Littlewood T; Potter M; Hunter A; Pagliuca A; Williams CD; Cook G; Towlson K; Marks David I; Russell NH;
Br J Haematol; 2005 Feb; 128(4):496-502. PubMed ID: 15686458
[TBL] [Abstract][Full Text] [Related]
38. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
39. Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamide.
Auner HW; Tinchon C; Brezinschek RI; Eibl M; Sormann S; Maizen C; Linkesch W; Schmon-Kampel R; Quehenberger F; Tiran A; Sill H
Eur J Haematol; 2002 Jul; 69(1):1-6. PubMed ID: 12270055
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of total body irradiation-cyclophosphamide versus busulphan-cyclophosphamide as conditioning regimens for myelogenous leukemia: a meta-analysis].
Xu SX; Tang XH; Chen HQ; Feng B; Xu HQ; Chen XP; Tang XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1354-60. PubMed ID: 19099643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
